Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

Posted by on Jan 9th, 2025

StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSO – Free Report) in a report published on Monday morning. The brokerage issued a hold rating on the stock.

EKSO has been the subject of several other research reports. Lake Street Capital cut their price objective on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. HC Wainwright cut their price target on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

View Our Latest Analysis on Ekso Bionics

Ekso Bionics Stock Performance

Shares of EKSO opened at $0.70 on Monday. The stock has a market capitalization of $15.40 million, a price-to-earnings ratio of -1.08 and a beta of 1.47. Ekso Bionics has a 12 month low of $0.50 and a 12 month high of $3.03. The firm has a fifty day simple moving average of $0.71 and a 200 day simple moving average of $0.96. The company has a current ratio of 2.81, a quick ratio of 2.14 and a debt-to-equity ratio of 0.28.

Ekso Bionics (NASDAQ:EKSO – Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. The company had revenue of $4.13 million during the quarter, compared to the consensus estimate of $6.00 million. During the same quarter in the previous year, the business earned ($0.24) EPS. Research analysts forecast that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Ekso Bionics Company Profile

(Get Free Report)

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

Read More

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.